Abbott Cardiovascular Systems Inc — Emissions Trend

Temecula, CA · 2019–2023 · Parent: Abbott Laboratories

This page assembles 5 consecutive years of EPA Toxics Release Inventory Form R filings for Abbott Cardiovascular Systems Inc, spanning 2019–2023. Each annual total aggregates on-site air emissions, surface-water discharges, land disposal, and off-site transfers reported by the facility under EPCRA Section 313, which requires disclosure whenever a listed chemical is manufactured, processed, or otherwise used above threshold quantities.

Reported releases opened at 242 in 2019 and closed at 395 in 2023 - a increasing of +63.1% over the window. The chart below stacks the four TRI release media (air, water, land, off-site) and overlays the yearly total. The top contributor by cumulative mass is Methanol at 2.0K.

Because TRI figures are estimated, not metered, year-over-year deltas can reflect methodology revisions, ownership changes, or shifts in what a facility classifies as reportable, not only physical emission changes. Treat the trajectory as a disclosure record, and cross-reference with the EPA Enforcement and Compliance History Online (ECHO) system for the fuller regulatory picture on this miscellaneous manufacturing facility.

Overall Trend
↑ Increasing (+63.1%)
2019 Total
242 lbs
2023 Total
395 lbs

Total Releases by Category

Air
Water
Land
Offsite Transfer
0180361541721902 20192020202120222023 Pounds Released

Year-over-Year Comparison

Year Total Chemicals YoY Change
2019 242 lbs 1
2020 222 lbs 1 -8.1%
2021 230 lbs 1 +3.2%
2022 902 lbs 1 +292.7%
2023 395 lbs 1 -56.2%

Top Chemicals by Year

Chemical 20192020202120222023 Total
Methanol 242 222 230 902 395 2.0K

About This Data

Trend data is sourced from the EPA Toxic Release Inventory (TRI). Facilities report annually. Release quantities are self-reported estimates. Year-over-year changes may reflect changes in production, pollution control measures, reporting methodology, or chemical thresholds.

A decrease in reported releases does not necessarily indicate improved environmental performance, as it may reflect production cutbacks, facility closures, or changes in reporting requirements. Similarly, increases may reflect expanded production rather than degraded environmental practices.

Frequently Asked Questions

Is Abbott Cardiovascular Systems Inc getting cleaner or dirtier?
Based on EPA TRI data from 2019–2023, Abbott Cardiovascular Systems Inc's total toxic releases have increased by approximately 63%.
What time period does this trend data cover?
This page shows 5 years of EPA Toxic Release Inventory data from 2019–2023. Release quantities are self-reported estimates filed annually by the facility.